Five-year survival following chemotherapy of non-small cell lung cancer.
Five-year survival of patients with inoperable non-small cell lung carcinoma is rare. We report a patient with inoperable large cell lung carcinoma who is apparently cured after receiving a course of combination chemotherapy. As the primary treatment of inoperable non-small cell carcinoma, we recommend combination chemotherapy over radiation therapy because: Chemotherapy gives a response rate of 30-40%; Quality of survival following chemotherapy appears better than following radiation therapy; Chemotherapy following radiation therapy appears to be ineffective.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011379:Prognosis; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D002945:Cisplatin; D005472:Fluorouracil; D008727:Methotrexate